Skip to content

The Effectiveness of Acupuncture for Delirium in Critically Ill Patients

The Effectiveness of Acupuncture for Delirium in Critically Ill Patients: a Double Blind Randomized Control Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04312893
Enrollment
80
Registered
2020-03-18
Start date
2020-03-12
Completion date
2022-05-30
Last updated
2021-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Agitation, Delirium, Intensive Care Unit Delirium

Keywords

Acupuncture, Critically ill, Intensive care, Delirium, Agitation

Brief summary

Introduction: Intensive care unit (ICU) delirium is an acute onset of brain dysfunction, which can affect 25-80% of ICU patients. Delirium is also associated with long term cognition impairment, higher mortality and higher ICU costs. Previous acupuncture studies showed the potential to prevent delirium. This study will examine the ability of acupuncture to treat ICU delirium. Methods: A double-blind randomized control trial will examine the effect of press tack acupuncture vs. press tack placebos. The patients will be randomly divided (1:1) into one of two groups. A total of 80 ICU patient will have to meet the following criteria: age 20-90, APACHE score \<30, Intensive Care Delirium Screening Checklist (ICDSC) \>4 points (indicates existing delirium), Richmond Agitation-Sedation Scale (RASS): +1, +2, +3, +4, -1, -2. Three interventions will be given in each group. The main outcomes will be the delirium days according to the ICDSC.

Detailed description

Introduction: Intensive care unit (ICU) delirium is an acute onset of brain dysfunction, which can affect 25-80% of ICU patients. Delirium is also associated with long term cognition impairment, higher mortality and higher ICU costs. Previous acupuncture studies showed the potential to prevent delirium. This study will examine the ability of acupuncture to treat ICU delirium. Methods: A double-blind randomized control trial will examine the effect of press tack acupuncture vs. press tack placebos. The patients will be randomly divided (1:1) into one of two groups. A total of 80 ICU patient will have to meet the following criteria: age 20-90, APACHE score \<30, Intensive Care Delirium Screening Checklist (ICDSC) \>4 points (indicates existing delirium), Richmond Agitation-Sedation Scale (RASS): +1, +2, +3, +4, -1, -2. Three interventions will be given in each group. The main outcomes will be the delirium days according to the ICDSC. Expected outcome: The study finding will help to determine the therapeutic effect of acupuncture for critically ill delirium patients. Furthermore, the study design will involve longer needle/placebos retention which is less investigated nowadays. Other information: This study will be conducted in the ICU departments of China medical hospital, Taichung city, Taiwan. The study is conducted on stable ICU patients and we don't anticipate any serious risk for adverse events following the intervention. The study will take place until May 2022. Keywords: acupuncture, critically ill, intensive care, delirium, agitation

Interventions

OTHERAcupuncture (Press Tack Needle)

Press Tack Needle (PYONEX made by Seirin Corporation). The needles appear identical to the press tack placebo with the only different is the needle itself which was removed in the placebo needles.

press tack placebo (made by Seirin Corporation), which looks identical to press tack needles but, with no needle element.

Sponsors

China Medical University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Our study goal is the measure the effectiveness of press tack needles (acupuncture group) in reducing delirium severity in critically ill patients in the ICU. In order to ensure a double bind procedure, we will implement the use of press tack placebos (control group) as a competitor. In addition to the mentioned above interventions, patients in both groups will receive routine ICU care as per individual patient's needs.

Intervention model description

two groups, randomized, pre-post intervention study

Eligibility

Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Age 20-90 * Apache score \<30 * Patients admitted in the ICU * Positive delirium score as: 4 or more points according to the Intensive Care Delirium Screening Checklist (ICDSC) * Richmond Agitation-Sedation Scale (RASS): +1, +2, +3, +4 -1, -2

Exclusion criteria

* Coagulopathy: Prolong Prothrombin Time (PPT) activated Partial Thromboplastin Time (aPTT) more than 4 times * Thrombocytopenia - low platelet count * Clinically unstable: receiving two inotropic agents or Fraction of Inspired Oxygen (FiO2) \>70% * Rass score: 0, -3, -4 (at the time of enrollment) * Primary central nervous system disorder: stroke, traumatic brain injury, central nervous system infections, brain tumors, recent intracranial surgery * Alcohol or substance withdrawal.

Design outcomes

Primary

MeasureTime frameDescription
Intensive Care Delirium Screening Checklist4 weeksA common delirium examination in the intensive care unit lowest score:1 ,highest score:8 , a score of 4 or higher indicates delirium

Secondary

MeasureTime frameDescription
mechanical ventilation in days4 weeksmechanical ventilation day is at least 5 hours under ventilator
intensive care unit (ICU) stay in days4 weeksnumber of days a patient stays in the intensive care unit
hospital stay in days4 weeksnumber of days a patient stays in the hospital
intensive care unit (ICU) mortality4 weeksthe number of patients die in the intensive care unit (ICU)
Richmond Agitation-Sedation Scale4 weeksA common scale to measure the severity on the delirium. The scale rates +4 to -4 Combative+4 Very agitated+3 Agitated+2 Restless+1 Alert and calm -0 Drowsy-1 Light sedation-2 Moderate sedation-3 Deep sedation-4
drug use4 weeksdaily dose of: sedative drugs, muscle relaxant or atypical antipsychotics
Blood pressureone hour before the interventionspatients systolic and diastolic blood pressure
heart rateone hour before the interventionspatients heart rate
hospital mortality4 weeksthe number of patients die in the hospital

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026